Objectives:

1. Review of mechanisms and outcomes of tricuspid regurgitation.

2. Describe the emerging transcatheter therapies for native valve tricuspid regurgitation including
         Trialign, TriCinch, FORMA, Mitraclip , and Cardioband.

3.  Review valve in valve treatment options and outcomes for bioproshtetic tricuspid valve Failure.

 

Session date: 
Friday, February 24, 2017 - 12:00pm to 1:00pm
Speaker Name: 
Charles J. Davidson, MD, FACC, FAHA, FSCAI
Location: 
UCMC W-632
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.